Guardian Pharmacy director converts 641,869 shares
Guardian Pharmacy Services, Inc. director and officer David K. Morris exercised a derivative position, converting 641,869 shares of Class B common stock into 641,869 shares of Class A common stock at an exercise price of $0.0000 per share.
Rhea-AI Filing Summary
Guardian Pharmacy Services, Inc. director and officer David K. Morris exercised a derivative position, converting 641,869 shares of Class B common stock into 641,869 shares of Class A common stock at an exercise price of $0.0000 per share.
Following the transaction on March 28, 2026, Morris directly owned 896,341 shares of Class A common stock. According to the company’s Amended and Restated Certificate of Incorporation, his Class B shares automatically convert into Class A shares on a one-for-one basis in substantially equal tranches on March 28, 2026 and September 27, 2026.
Positive
- None.
Negative
- None.
Insider Trade Summary
641,869 shares exercised/converted
Exercise
2 txns
Insider
Morris David K
Role
See Remarks
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Class B Common Stock | 641,869 | $0.00 | $0.00 |
| Exercise | Class A Common Stock | 641,869 | $0.00 | $0.00 |
Holdings After Transaction:
Class B Common Stock — 641,870 contracts (Direct);
Class A Common Stock — 896,341 shares (Direct)
Footnotes (1)
- F1. Pursuant to Guardian Pharmacy Services, Inc.'s (the "Issuer") Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of March 28, 2026 and September 27, 2026.
Key Figures
Derivative exercise: 641,869 shares
Exercise price: $0.0000 per share
Class A holdings after transaction: 896,341 shares
+1 more
4 metrics
Derivative exercise
641,869 shares
Class B common stock converted to Class A on March 28, 2026
Exercise price
$0.0000 per share
Conversion of Class B into Class A common stock
Class A holdings after transaction
896,341 shares
Direct ownership of Class A common stock following March 28, 2026 conversion
Automatic conversion schedule
Two tranches
Substantially equal tranches on March 28, 2026 and September 27, 2026
Key Terms
Class B common stock, Class A common stock, Amended and Restated Certificate of Incorporation, Exercise or conversion of derivative security
4 terms
Class B common stock financial
"the Reporting Person's shares of Class B common stock automatically convert"
A class B common stock is one of multiple types of a company’s ordinary shares that carries specific rights—often different voting power or dividend priority—compared with other classes. For investors it matters because those differences affect how much influence you have over company decisions, the income you might receive, and how freely the shares trade; think of it like owning a car with different keys: some keys let you start the engine and open the trunk, others only unlock the door.
Class A common stock financial
"convert into shares of the Issuer's Class A common stock, on a one-for-one basis"
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
Amended and Restated Certificate of Incorporation regulatory
"Pursuant to Guardian Pharmacy Services, Inc.'s Amended and Restated Certificate of Incorporation"
A company’s amended and restated certificate of incorporation is an updated version of its foundational legal charter that replaces the older document and folds in all changes into one clear copy; it spells out corporate structure, classes of stock, shareholder rights and key governance rules. Investors care because it can change who controls the company, how votes are counted, what claims shareholders have on assets or dividends, and can introduce or remove protections against takeovers—like updating a house title after a major renovation to show who owns what and under what rules.
Exercise or conversion of derivative security financial
"transaction_code_description: Exercise or conversion of derivative security"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did GRDN director David K. Morris report?
David K. Morris reported exercising a derivative position to convert 641,869 shares of Class B common stock into 641,869 shares of Class A common stock at an exercise price of $0.0000 per share, reflecting an automatic conversion under the company’s charter.
What happened to David K. Morris’s Class B common stock in GRDN?
A tranche of David K. Morris’s Class B common stock automatically converted into 641,869 shares of Class A common stock on March 28, 2026, on a one-for-one basis, pursuant to Guardian Pharmacy’s Amended and Restated Certificate of Incorporation.
Was the GRDN insider transaction a market buy or sell?
The transaction was not an open-market buy or sell. It was an exercise or conversion of a derivative security, moving 641,869 shares from Class B common stock into Class A common stock at an exercise price of $0.0000 per share, with no market trade reported.
AI-generated analysis. How Rhea-AI works. Not financial advice.
